NITI Aayog to Launch Blueprint for National Brain Health

To address the rising burden of neurological disorders, including Alzheimer's, Parkinson’s, epilepsy, and stroke, in India, NITI Aayog is gearing up to launch a National Brain Health Blueprint focusing on improving brain health and identifying...

Andhra Pradesh Issues Covid-19 Warning, Urges Precautions

Amid the renewed surge in Covid-19 cases across the country, Andhra Pradesh Information and Public Relations Minister K Parthasarathi on Sunday called on citizens to stay alert and follow precautionary guidelines...

FDA Approves Moderna's mNEXSPIKE Vaccine for Aged 65 & Above

The U.S. Food and Drug Administration (FDA) has given Moderna’s approval for mNEXSPIKE to be used in seniors aged 65 and above.

HN Reliance Launches Fastest AI 3D Mammography in South Asia

In a significant advancement for women's health, Sir H. N. Reliance Foundation Hospital in Mumbai has now launched South Asia's first and fastest Genius AI 3D Mammography system, transforming breast cancer screening with AI-enabled diagnosis...

Alembic Pharma Achieves Major Milestone with USFDA Nod for Cancer Treatment

The US Food and Drug Administration (USFDA) have granted Alembic Pharmaceuticals final approval for their Abbreviated New Drug Application

ICMR Launches Books on Indian Medicinal Plants for Drug Use

The Indian Council of Medical Research (ICMR) published the Volumes 30 & 31, showcasing Indian medicinal plants, completing an exhaustive review of plant species A-Z through their 31 volumes...

AstraZeneca Secures CDSCO Approval for Benralizumab in India

AstraZeneca Pharma India has been given permission by the Central Drugs Standard Control Organization Directorate General of Health Services Government of India

India Sets New Date for MEG Anti-Dumping Probe Hearing

The Directorate General of Trade Remedies (DGTR) has rescheduled the oral hearing for its ongoing anti-dumping investigation into imports of mono ethylene glycol (MEG) from Kuwait, Saudi Arabia, and Singapore...

FDA Grants Priority Review to Bayer's NSCLC Drug Sevabertinib

Bayer announced that its investigational drug, sevabertinib, has been granted Priority Review by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with advanced non-small...

West Bengal Strengthens Pharma Safety Net with GPP Implementation by DCA

The introduction of Good Purchasing Practices (GPP) by the West Bengal Drugs Control Administration (WB DCA)

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.